China has opened its first wholly foreign-owned tertiary general hospital to international patients, an early test of the country’s move to let foreign operators run hospitals on their own. Global Times reported that Perennial General Hospital Tianjin, which opened in February 2025, had treated nearly 14,000 people by late January, including more than 300 international patients from 24 countries and regions. The hospital is small against China’s scale, but the ownership model is new, and that is what makes it worth watching.
A wholly foreign-owned hospital in Tianjin
Perennial General Hospital Tianjin is run by Perennial Holdings, the Singapore group whose executive chairman and chief executive is Pua Seck Guan. Global Times reported that the hospital sits within a pilot programme designed to broaden foreign access to China’s healthcare sector. Liu Dan, the hospital’s president, described a dual role for the site, in that it serves residents and foreigners living in China while opening a new route for international patients who want to travel to China for care. That second function is the medical tourism story, and it is deliberate rather than incidental.
Cross-border patients and the Mongolian case
Global Times reported the case of a patient from Mongolia who completed an initial course of chemotherapy at the hospital, after which her tumour marker levels improved. Pua Seck Guan framed the wider signal in investment terms, saying “China’s opening-up policies in the healthcare sector send a positive signal.” For a country like Mongolia, with limited advanced oncology capacity of its own, a tertiary hospital across the border is a natural destination, and cases like this one show how neighbouring markets can become inbound source markets for Chinese hospitals. The five familiar drivers of medical travel apply here in their bluntest form, which is care that is simply not available, or not yet available, at home. Better, best, cheaper, faster, or unavailable at home are the five drivers, and Mongolia’s oncology gap falls squarely under the last of them. A neighbouring market with thin advanced-oncology capacity is a natural referral corridor for a tertiary hospital in Tianjin. That corridor cuts both ways. A hospital that leans on one source market also inherits that market’s politics, currency and referral patterns, and concentration in a single source market is a familiar fragility in destination healthcare. Perennial General Hospital Tianjin will need referral breadth across more than one border to turn early cases into a durable inbound stream.
What foreign ownership changes for medical tourism
For international patients, the choice of a hospital abroad turns largely on trust, and foreign ownership is one way to signal a familiar standard of governance and clinical practice. A wholly foreign-owned tertiary hospital can carry the operating standards and accountability that a cross-border patient recognises, which lowers one of the barriers that keeps medical travel cautious. This does not remove the real risks of medical travel, which run from clinical outcomes to legal redress and continuity of care once a patient goes home. It does change the trust calculation at the front end, and that is where most cross-border decisions are actually made. Trust is the scarce currency in medical tourism, and it is more often sold than earned. Facilitators and agents trade on visibility, ranking a hospital by how well it markets rather than by how well it treats. A wholly foreign-owned operator answers a different question, which is who is accountable when a cross-border case goes wrong. Ownership signals a governance chain that an international patient can follow, from the Singapore parent to the Tianjin ward. That signal does not replace accreditation, outcomes data or a clear redress route, and cross-border patients should still ask for all three before travelling.
Policy behind the Tianjin pilot
The hospital is one strand of a broader opening in Chinese healthcare. Global Times reported that China’s 2026 government work report set out plans to widen market entry in services, naming value-added telecommunications, biotechnology and wholly foreign-owned hospitals among the areas opened to further foreign participation. The country’s 15th Five-Year Plan, covering 2026 to 2030, restates a commitment to what it calls high-standard opening up. For medical tourism the relevant part is narrow and concrete, which is that foreign operators can now build and run tertiary hospitals in China and market them to patients beyond its borders.
Neighbouring markets and the destination economy
A hospital that draws patients across a border reshapes more than its own ward list. Inbound medical travel pulls in interpreters, aftercare hotels, visa handling and repatriation logistics, and that trickle-down destination economy is often where the local gains concentrate. The risk is that the gains stay narrow. Tianjin captures the surgical and oncology fees, while the referring country keeps the diagnosis, the follow-up and the long-term monitoring, and the balance of value depends on who owns the continuity of care. The specialties that travel best are oncology, cardiology, orthopaedics and reproductive medicine, where a diagnosis made abroad can outrun a waiting list at home. Medical tourism is, at its root, a symptom of where advanced capacity sits and where it does not, and China is now positioning itself on the supplying side of that inequality rather than the demand side it occupied for years.
The honest read on Perennial Tianjin
This is a pilot at an early stage, and the numbers say as much. More than 300 international patients from 24 countries is a promising start, not a destination in its own right, and one hospital in Tianjin does not make China a medical tourism hub. The signal that matters is structural rather than statistical. If wholly foreign-owned hospitals prove they can run to international standards and draw patients from neighbouring markets, the model will spread faster than any single hospital’s caseload. Perennial General Hospital Tianjin is worth tracking not for what it has treated so far, but for the ownership template it is testing.
